Market Research Logo

Implantable Biomaterials Global Market - Forecast to 2022

Implantable Biomaterials Global Market - Forecast to 2022

A biomaterial is any substance of metallic, polymer, ceramic or natural origin that is suitable for introducing into living tissue as an implant without adversely affecting the patient. The biomaterial implants have been enormously successful and have enhanced the life of millions of patients. There is continuous ongoing research to develop next generation advanced biomaterials like bioabsorbable materials, bioactive and smart biomaterials, shape memory biomaterials etc. Next generation of biomaterials will have better prospect from the current research and innovations taking placing in biomaterials field.

This report concentrates on biomaterials that are used in the manufacturing of implant devices. The non-implant devices like catheters, guide wires and biomaterials in tissue engineering are not considered in implantable biomaterials report. Also, autografts and xenograft are not taken into account, only mass manufacture biomaterials are described in the report.

The Implantable Biomaterials market is classified based on type of materials, application, and geography. By material type, the market is segmented into Metal and Metal alloys, Synthetic Polymers, Ceramics, Natural biomaterials and Composites. By application, implantable biomaterials market is segmented into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Ophthalmology, Neurology and other Applications. Geographical wise, the transplantation market is segmented into North America, Europe, Asia- Pacific and Rest of the world.

Among the implantable biomaterials by type, the synthetic polymers are dominating the market by occupying a largest share and synthetic polymers are expected to grow at a highest CAGR from 2015 to 2022. The synthetic polymers market by type is segmented into Polyetheretherketone, polytetrafluoroethylene, Polyethylene terephthalate, Polyethylene, Polymethylmethacrylate, Polyurethanes, Silicone, Resorbable polymers, Hydrogels and others. Among these, Polyetheretherketone accounts for major share in synthetic polymers segment and Resorbable polymers are expected to grow at strong CAGR from 2016 to 2023 . By applications, the market is segmented into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Ophthalmology, Neurology and other Applications. Among these, Orthopedic application accounts for largest share of application market and Wound healing is growing at strong CAGR from 2016 to 2023.

The global implantable biomaterials market is expected to grow at single digit CAGR to reach $21,124.2 million by 2022. The factors driving the growth of this market are increasing ageing population, increase in Research and development investments, increasing applications of biomaterials, growing demand for plastic surgery, and reimbursements offered by Center for Medicare and Medicaid Services. However, stringent regulatory processes for approval of biomaterials and biomaterials based implant devices and limitations of biomaterials like complications due to implant rejection, cytotoxicity, and corrosion of biomaterials implant are hampering the growth of implantable biomaterials market.

The implantable biomaterials market is a highly fragmented market. Major players in Biomaterial market include Solvay Advanced Polymers, LLC (Belgium), Evonik Industries AG (Germany), Carpenter Technology Corporation (U.S.), DSM Biomedical, Inc. (Royal DSM) (Netherlands), Johnson Matthey Plc (U.K.), Morgan Advanced Materials plc (U.K.), Materion (U.S.), Victrex PLC (Invibio Biomaterial Solutions ) (U.K.) and Collagen solutions (U.K.), Corbion N.V. (Netherlands), Landec Corporation (U.S.).


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Advances in 3D printing of biomaterials
3.3.1.2 Increasing Aging Population
3.3.1.3 Miniaturization of implant devices and increasing minimally invasive surgery
3.3.1.4 Demand for Orthopedic Implants
3.3.1.5 Increasing R&D investments
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Limitations of biomaterial-base products
3.3.2.2 Stringent Regulatory Processes for Approval of Biomaterials & Biomaterial based products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.2 U.S.
3.4.3 EUROPE
3.4.4 CHINA
3.4.5 CANADA
3.4.6 INDIA
3.5 TECHNOLOGICAL ADVANCEMENTS
3.5.1 INTRODUCTION
3.5.2 SMART BIOMATERIALS
3.5.3 SHEAR-THINNING BIOMATERIALS (STB)
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 BARGAINING POWER OF SUPPLIERS
3.6.4 BARGAINING POWER OF BUYERS
3.6.5 RIVALRY AMONG EXISTING COMPETITORS
3.7 SUPPLY CHAIN ANALYSIS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 IMPLANTABLE BIOMATERIALS GLOBAL MARKET, BY SOURCE
4.1 INTRODUCTION
4.2 METALS AND METAL ALLOYS
4.2.1 TITANIUM AND TITANIUM ALLOYS
4.2.2 COBALT-CHROME ALLOYS
4.2.3 STAINLESS STEEL
4.2.4 MAGNESIUM AND MAGNESIUM ALLOYS
4.2.5 OTHER METALLIC BIOMATERIALS
4.3 SYNTHETIC POLYMERS
4.3.1 INTRODUCTION
4.3.2 POLYETHERETHERKETONE (PEEK)
4.3.3 POLYTETRAFLU0ROETHYLENE (PTFE)
4.3.4 POLYETHYLENE TEREPHTHALATE (PETE)
4.3.5 POLYETHYLENE (UHMWPE)
4.3.6 POLYMETHYLMETHACRYLATE (PMMA)
4.3.7 POLYURETHANES
4.3.8 SILICONE
4.3.9 RESORBABLE POLYMERS
4.3.10 HYDROGELS
4.3.11 OTHER SYNTHETIC POLMERS
4.4 CERAMICS
4.4.1 CALCIUM COMPOSITIONS
4.4.2 ALUMINUM OXIDE
4.4.3 ZIRCONIA
4.4.4 CARBON
4.4.5 GLASS
4.4.6 SILICON NITRIDE
4.5 NATURAL BIOMATERIALS
4.5.1 INTRODUCTION
4.5.2 CELLULOSE
4.5.3 COLLAGEN AND GELATIN
4.5.4 HYALURONIC ACID
4.5.5 FIBRIN
4.5.6 CHITIN/CHITOSAN
4.5.7 ELASTIN
4.5.8 SILK
4.5.9 OTHER NATURAL BIOMATERIALS
4.6 COMPOSITES
5 IMPLANTABLE BIOMATERIALS GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 CARDIOVASCULAR
5.2.1 STENTS
5.2.2 HEART VALVE REPAIR AND REPLACEMENT
5.2.3 VASCULAR GRAFTS
5.2.4 PACMAKERS AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
(ICDS)
5.2.5 OTHERS
5.3 ORTHOPEDIC APPLICATION
5.3.1 JOINT REPAIR AND REPLACEMENT
5.3.2 SPINE
5.3.3 ORTHOBIOLOGICS
5.3.4 OTHER ORTHOPEDIC APPLICATION
5.4 DENTAL
5.4.1 DENTAL IMPLANTS
5.4.2 DENTAL BONE GRAFTS AND SUBSTITUTES
5.4.3 DENTAL MEMBRANES
5.5 PLASTIC SURGERY
5.5.1 BIOENGINEERED SKINS
5.5.2 SOFT TISSSUE FILLERS
5.5.3 COSMETIC IMPLANTS
5.5.4 CRANIOFACIAL SURGERY
5.6 WOUND HEALING
5.6.1 WOUND CLOSURE
5.6.1.1 Sutures
5.6.1.2 Staples
5.6.1.3 Ligating clips
5.6.2 SYNTHETIC SKIN SUBSTITUTES
5.6.3 TAPES AND ADHESIVES
5.6.4 HEMOSTATS
5.6.5 SEALANTS
5.7 OPHTHALMOLOGY
5.7.1 CONTACT LENS
5.7.2 INTRAOCULAR LENS
5.7.3 OCULAR REPLACEMENT
5.7.4 SYNTHETIC CORNEA
5.7.5 VITREOUS BODY REPLACEMENT
5.8 NEUROLOGY APPLICATIONS
5.8.1 SHUNTING SYSTEMS
5.8.2 CORTICAL NEURAL PROSTHETICS
5.8.3 NERVE CONDUITS
5.9 OTHER APPLICATIONS
5.9.1 GASTROINTESTINAL
5.9.2 SURGICAL MESH
5.9.3 COCHLEAR IMPLANT
5.9.4 IMPLANTABLE INFUSION PUMPS
5.9.5 OTHER STENTS AND VASCULAR GRAFTS
5.9.6 OTHERS
6 REGIONAL ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 U.S.
6.2.2 OTHERS
6.3 EUROPE
6.3.1 GERMANY
6.3.2 U.K.
6.3.3 FRANCE
6.3.4 OTHERS
6.4 ASIA - PACIFIC
6.4.1 JAPAN
6.4.2 CHINA
6.4.3 INDIA
6.4.4 OTHERS
6.5 REST OF THE WORLD
6.5.1 LATIN AMERICA
6.5.2 MIDDLE EAST
6.5.3 OTHERS
7 MAJOR COMPANIES
7.1 CARPENTER TECHNOLOGY CORPORATION
7.1.1 OVERVIEW
7.1.2 FINANCIALS
7.1.3 PRODUCT PORTFOLIO
7.1.4 KEY DEVELOPMENTS
7.1.5 BUSINESS STRATEGY
7.1.6 SWOT ANALYSIS
7.2 COLLAGEN SOLUTIONS
7.2.1 OVERVIEW
7.2.2 FINANCIALS
7.2.3 PRODUCT PORTFOLIO
7.2.4 KEY DEVELOPMENTS
7.2.5 BUSINESS STRATEGY
7.2.6 SWOT ANALYSIS
7.3 CORBION NV
7.3.1 OVERVIEW
7.3.2 FINANCIALS
7.3.3 PRODUCT PORTFOLIO
7.3.4 KEY DEVELOPMENTS
7.3.5 BUSINESS STRATEGY
7.3.6 SWOT ANALYSIS
7.4 EVONIK INDUSTRIES AG
7.4.1 OVERVIEW
7.4.2 FINANCIALS
7.4.3 PRODUCT PORTFOLIO
7.4.4 KEY DEVELOPMENTS
7.4.5 BUSINESS STRATEGY
7.4.6 SWOT ANALYSIS
7.5 JOHNSON MATTHEY PLC
7.5.1 OVERVIEW
7.5.2 FINANCIALS
7.5.3 PRODUCT PORTFOLIO
7.5.4 KEY DEVELOPMENTS
7.5.5 BUSINESS STRATEGY
7.5.6 SWOT ANALYSIS
7.6 LANDEC CORPORATION
7.6.1 OVERVIEW
7.6.2 FINANCIALS
7.6.3 PRODUCT PORTFOLIO
7.6.4 KEY DEVELOPMENTS
7.6.5 BUSINESS STRATEGY
7.6.6 SWOT ANALYSIS
7.7 MATERION CORPORATION
7.7.1 OVERVIEW
7.7.2 FINANCIALS
7.7.3 PRODUCT PORTFOLIO
7.7.4 KEY DEVELOPMENTS
7.7.5 BUSINESS STRATEGY
7.7.6 SWOT ANALYSIS
7.8 MORGAN ADVANCED MATERIALS PLC
7.8.1 OVERVIEW
7.8.2 FINANCIALS
7.8.3 PRODUCT PORTFOLIO
7.8.4 KEY DEVELOPMENTS
7.8.5 BUSINESS STRATEGY
7.8.6 SWOT ANALYSIS
7.9 ROYAL DSM BIOMEDICAL
7.9.1 OVERVIEW
7.9.2 FINANCIALS
7.9.3 PRODUCT PORTFOLIO
7.9.4 KEY DEVELOPMENTS
7.9.5 BUSINESS STRATEGY
7.9.6 SWOT ANALYSIS
7.10 SOLVAY SA
7.10.1 OVERVIEW
7.10.2 FINANCIALS
7.10.3 PRODUCT PORTFOLIO
7.10.4 KEY DEVELOPMENTS
7.10.5 BUSINESS STRATEGY
7.10.6 SWOT ANALYSIS
7.11 VICTREX PLC
7.11.1 OVERVIEW
7.11.2 FINANCIALS
7.11.3 PRODUCT PORTFOLIO
7.11.4 KEY DEVELOPMENTS
7.11.5 BUSINESS STRATEGY
7.11.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report